Garry S. Tobin

677 total citations
19 papers, 521 citations indexed

About

Garry S. Tobin is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Garry S. Tobin has authored 19 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Surgery and 4 papers in Genetics. Recurrent topics in Garry S. Tobin's work include Diabetes Management and Research (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers) and Diabetes and associated disorders (3 papers). Garry S. Tobin is often cited by papers focused on Diabetes Management and Research (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers) and Diabetes and associated disorders (3 papers). Garry S. Tobin collaborates with scholars based in United States, United Kingdom and China. Garry S. Tobin's co-authors include Peter Rotwein, Janet B. McGill, Michael Elliott, David P. Bichell, Yoshitaka Kajimoto, Debra Counts, Rosanne Naunheim, Anitha Vijayan, Nils Brünner and Douglas Yee and has published in prestigious journals such as Diabetes Care, Diabetes and Molecular Endocrinology.

In The Last Decade

Garry S. Tobin

19 papers receiving 508 citations

Peers

Countries citing papers authored by Garry S. Tobin

Since Specialization

Citations

This map shows the geographic impact of Garry S. Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry S. Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry S. Tobin more than expected).

Fields of papers citing papers by Garry S. Tobin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry S. Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry S. Tobin. The network helps show where Garry S. Tobin may publish in the future.

Co-authorship network of co-authors of Garry S. Tobin

This figure shows the co-authorship network connecting the top 25 collaborators of Garry S. Tobin. A scholar is included among the top collaborators of Garry S. Tobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry S. Tobin. Garry S. Tobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease 2018 ·Diabetes Care ·Jing W. Hughes, (unknown), Maamoun Salam, (unknown), (unknown), Kavita Juneja, (unknown), (unknown), (unknown), (unknown), Garry S. Tobin, Janet B. McGill	31
2	Sustainability of a Real-Time Informatics Alert to Prevent Inpatient Severe Hypoglycemia 2018 ·Diabetes ·Michael Elliott, (unknown), Kevin Heard, Paul E. Milligan, (unknown), Garry S. Tobin	2
3	A Systematic Approach for the Prevention and Reduction of Hypoglycemia in Hospitalized Patients 2017 ·Current Diabetes Reports ·(unknown), (unknown), Garry S. Tobin	9
4	High-Risk Gastric Pathology and Prevalent Autoimmune Diseases in Patients with Pernicious Anemia 2017 ·Endocrine Practice ·Jing W. Hughes, Brian D. Muegge, Garry S. Tobin, Marina Litvin, Lulu Sun, José B. Sáenz, C. Prakash Gyawali, Janet B. McGill	18
5	Effect of a glucagon receptor antibody (REMD‐477) in type 1 diabetes: A randomized controlled trial 2017 ·Diabetes Obesity and Metabolism ·Jeremy Pettus, Dominic N. Reeds, Tricia Santos Cavaiola, Schafer Boeder, (unknown), Garry S. Tobin, Edda Cava, Dung Thai, Jim Shi, Hai Yan, (unknown), (unknown), Roger H. Unger, Robert R. Henry, Samuel Klein	50
6	Weight‐based insulin dosing for acute hyperkalemia results in less hypoglycemia 2016 ·Journal of Hospital Medicine ·(unknown), (unknown), (unknown), Eli N. Deal, Garry S. Tobin	34
7	Improving Diabetes Care with Technology and Information Management. 2016 ·PubMed ·Brian D. Muegge, Garry S. Tobin	4
8	Prevention of inpatient hypoglycemia with a real‐time informatics alert 2014 ·Journal of Hospital Medicine ·(unknown), Michael Elliott, (unknown), (unknown), (unknown), Kevin Heard, Janet B. McGill, Mark Thoelke, Garry S. Tobin	34
9	Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy 2012 ·International Journal of Clinical Practice ·Garry S. Tobin, Melissa K. Cavaghan, Byron J. Hoogwerf, Janet B. McGill	12
10	Prediction and Prevention of Treatment-Related Inpatient Hypoglycemia 2012 ·Journal of Diabetes Science and Technology ·Michael Elliott, (unknown), Janet B. McGill, Garry S. Tobin	48
11	Incidence of hypoglycemia following insulin‐based acute stabilization of hyperkalemia treatment 2011 ·Journal of Hospital Medicine ·(unknown), Rosanne Naunheim, Anitha Vijayan, Garry S. Tobin	52
12	Inpatient insulin orders: Are patients getting what is prescribed? 2011 ·Journal of Hospital Medicine ·Eli N. Deal, (unknown), (unknown), (unknown), Garry S. Tobin	21
13	Policy Implementation for Inpatient Management of U-500 Insulin Resulting in Lower Incidence of Hypoglycemia 2011 ·Endocrine Practice ·Eli N. Deal, Garry S. Tobin, Akif Altınbaş, Fuat Ekız, (unknown), Ömer Başar, Osman Yüksel	5
14	A Case Of Severe Neuropat Hy Associated With Hypertriglyceridemia 2008 ·Endocrine Practice ·Runhua Hou, Anne C. Goldberg, Garry S. Tobin	5
15	Inpatient Glycemic Control on the Vascular Surgery Service 2008 ·Endocrine Practice ·(unknown), (unknown), (unknown), Amy E. Riek, Janet B. McGill, (unknown), Garry S. Tobin	16
16	Functional Analysis of the Rat Insulin-Like Growth Factor I Gene and Identification of an IGF-I Gene Promoter 1992 ·DNA and Cell Biology ·(unknown), Yoshitaka Kajimoto, David P. Bichell, (unknown), (unknown), Debra Counts, (unknown), Garry S. Tobin, Peter Rotwein	122
17	A Novel Human Insulin-Like Growth Factor I Messenger RNA is Expressed in Normal and Tumor Cells 1990 ·Molecular Endocrinology ·Garry S. Tobin, Douglas Yee, Nils Brünner, Peter Rotwein	52
18	A clinical trial of levamisole in primary biliary cirrhosis 1982 ·Postgraduate Medical Journal ·(unknown), Garry S. Tobin, P.J. Ciclitira	3
19	Charting v computers in a postoperative cardiothoracic ITU. 1978 ·PubMed ·Jacquelyn Miller, (unknown), (unknown), Jon S. Bailey, Garry S. Tobin	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact